Ultragenyx Stock Market Value
| RARE Stock | USD 48.13 0.77 1.63% |
| Symbol | Ultragenyx |
Ultragenyx Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.45) | Revenue Per Share 6.015 | Quarterly Revenue Growth 0.423 | Return On Assets (0.24) | Return On Equity (2.90) |
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ultragenyx 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ultragenyx's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ultragenyx.
| 06/01/2024 |
| 11/28/2024 |
If you would invest 0.00 in Ultragenyx on June 1, 2024 and sell it all today you would earn a total of 0.00 from holding Ultragenyx or generate 0.0% return on investment in Ultragenyx over 180 days. Ultragenyx is related to or competes with X4 Pharmaceuticals, Terns Pharmaceuticals, Day One, PDS Biotechnology, Inozyme Pharma, Amylyx Pharmaceuticals, and Apellis Pharmaceuticals. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, an... More
Ultragenyx Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ultragenyx's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ultragenyx upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 8.73 | |||
| Value At Risk | (3.20) | |||
| Potential Upside | 2.65 |
Ultragenyx Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ultragenyx's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ultragenyx's standard deviation. In reality, there are many statistical measures that can use Ultragenyx historical prices to predict the future Ultragenyx's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.55) | |||
| Treynor Ratio | (0.40) |
Ultragenyx Backtested Returns
Ultragenyx owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.12, which indicates the firm had a -0.12% return per unit of risk over the last 3 months. Ultragenyx exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Ultragenyx's Coefficient Of Variation of (754.08), risk adjusted performance of (0.1), and Variance of 3.67 to confirm the risk estimate we provide. The entity has a beta of 0.67, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Ultragenyx's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ultragenyx is expected to be smaller as well. At this point, Ultragenyx has a negative expected return of -0.24%. Please make sure to validate Ultragenyx's value at risk, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if Ultragenyx performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.93 |
Near perfect reversele predictability
Ultragenyx has near perfect reversele predictability. Overlapping area represents the amount of predictability between Ultragenyx time series from 1st of June 2024 to 30th of August 2024 and 30th of August 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ultragenyx price movement. The serial correlation of -0.93 indicates that approximately 93.0% of current Ultragenyx price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.93 | |
| Spearman Rank Test | -0.73 | |
| Residual Average | 0.0 | |
| Price Variance | 15.93 |
Ultragenyx lagged returns against current returns
Autocorrelation, which is Ultragenyx stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ultragenyx's stock expected returns. We can calculate the autocorrelation of Ultragenyx returns to help us make a trade decision. For example, suppose you find that Ultragenyx has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ultragenyx regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ultragenyx stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ultragenyx stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ultragenyx stock over time.
Current vs Lagged Prices |
| Timeline |
Ultragenyx Lagged Returns
When evaluating Ultragenyx's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ultragenyx stock have on its future price. Ultragenyx autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ultragenyx autocorrelation shows the relationship between Ultragenyx stock current value and its past values and can show if there is a momentum factor associated with investing in Ultragenyx.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:Check out Ultragenyx Correlation, Ultragenyx Volatility and Ultragenyx Alpha and Beta module to complement your research on Ultragenyx. For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Ultragenyx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.